Feature | SCAI | May 01, 2017

Late-Breaking Clinical Trial Presentations at SCAI 2017

a list of SCAI late breaking trial presentations

May 30, 2017 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions took place May 10-13, 2017 in New Orleans. The annual meeting included several late-breaking presentations on the latest advances in interventional cardiology. Article links are included for the key presentations.

 

Late-breaking Study Presentations

Adventitial Dexamethasone Reduces Inflammatory Biomarker Levels After Peripheral Artery Balloon Angioplasty or Atherectomy: Results from the DANCE Trial. Presented by Ehrin J. Armstrong, M.D., MSc, MAS, FSCAI.

CD34+ Stem Cell Therapy Improves Exercise Time and Mortality in Refractory Angina: A Patient Level Meta-Analysis. Presented by Thomas J. Povsic, M.D., Ph.D.

Effect of Bivalirudin Versus Unfractionated Heparin in Patients with Baseline or New-Onset Atrial Fibrillation in Transcatheter Aortic Valve Replacement: From the BRAVO-3 Randomized Trial. Presented by Anita W. Asgar

Clopidogrel Response Evaluation and Anti-Platelet Intervention in High Thrombotic Risk PCI Patients (CREATIVE trial). Presented by Yida Tang, M.D., Ph.D., FSCAI.

Impact of Valve Design and Bivalirudin vs. Unfractionated Heparin for Anticoagulation in Transcatheter Aortic Valve Replacement: Results from the BRAVO-3 trial. Presented by Axel Linke, M.D.

Interaction Effects of Race/Ethnicity and Sex on Outcomes after PCI: A Subanalysis of the PLATINUM Diversity study. Presented by Wayne B. Batchelor, M.D., MHS, FSCAI.

Outcomes of Early vs. Late Revascularization in Low and High Risk Patients Hospitalized with Non ST-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study. Presented by Sameer Arora, M.D., at 11:30 a.m. 

Efficacy and Safety Outcomes of Radial vs. Femoral-Access Robotic Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION Registry. Presented by Ehtisham Mahmud, M.D., FSCAI.

• Day of the Week PCI-Related Hospitalization Occurs Determines Likelihood of Survival. Presented by Byomesh Tripathi, M.D.

 

SCAI Video Coverage

Watch VIDEO coverage of key SCAI 2017 news, courses and trials at www.youtube.com/playlist?list=PLYpLxw1Ganwa5kJFa3TrFAY5l1-Jeu9Ax

 

Late-breaking Trials From TCT and ACC: 

ACC 2017 Late-Breaking Trials

TCT 2016 Late-breaking Trials and First Reports

 

For more information: www.scai.org/SCAI2017/default.aspx

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...